Diagnostic and Biotech

New Frontiers in the UK Automated Microbiology Market: Business Challenges, Emerging Technologies, Competitive Landscape

  • VPG16155
  • 0 Pages
  • May 2014
  • Diagnostic and Biotech

Complete report $6,950. DataPack (test volumes, sales forecasts, supplier shares) $4,500.


New Frontiers in theUK Automated Microbiology Markets: Business Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Groups new analysis of the major business opportunities emerging in the automated microbiology market during the next five years. The report examines key trends in theUK automated microbiology market; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures, as well as over 100 infectious disease tests by assay, application, market segment, profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.


Rationale


The level of automation in the microbiology laboratory has been lagging behind that of other major clinical laboratory segments, such as chemistry and hematology. The slow acceptance of the technology is in part due to the complexity of developing automation suitable for microbiology tests.


The introduction of automated microbiology instrumentation has been delayed by a number of intrinsic and technical problems. The diffusion of automated microbiology systems, once the technology was developed, has not matched that of other automated laboratory technologies. The acquisition of automation in microbiology has been slowed by forces less easily identifiable than the effects of various reimbursement plans. Some laboratorians still believe that current instrumentation is not the ultimate technology and expect better automation on the horizon.


The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expense are coming under severe scrutiny worldwide.


This comprehensive report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology market, in evaluating emerging opportunities and developing effective business strategies.


Supplier Shares, Sales and Volume Forecasts


- Sales and market shares of major suppliers of

microbiology products, by individual test.


- Five-year test volume and sales forecasts for over 100 microbiology

assays.


- Test volume estimates by method (molecular, serology/immunodiagnostics,

culture/microscopy).


UKMarket Overview


- Review of the market dynamics, trends, structure, size, growth

and major suppliers.


- Estimated universe of laboratories performing microbiology testing.


- Specimen, test volume and sales forecasts.


Business Opportunities and Strategic Recommendations


- Emerging opportunities for new analyzers, reagents kits, IT

and other products with significant market appeal during the next five years.


- Design criteria for decentralized testing products.


- Alternative market penetration strategies.


- Potential market entry barriers and risks.


Specimen Types


- Urine

- Sterile Fluids: Blood, Serum, CSF

- Throat Swabs, Respiratory Secretions

- Genital Secretions

- Stool

- Abscess/Wound

- Sputum

- Saliva


Applications


- Microbial Identification

- Antibiotic Susceptibility

- Urine Screening

- Blood Cultures


Review of Major Automated Systems


- Review of major automated molecular diagnostic, multipurpose, specialized,

microbial identification, antibiotic susceptibility, blood culture, urine screening,

and immunodiagnostic analyzers.


- The report features analyzers manufactured by Abbott, Alifax, Anagen,

BD, Beckman Coulter/Danaher, Biochem, Biolog, bioMerieux, Bio-Rad,

Biotrol, Cepheid, Curetis, GenMark, Hologic/Gen-Probe, HTG, Iris, J&J,

Labsystems, Life Technologies, MiDI, Olympus, Qiagen, Roche, Siemens,

Sy-Lab, Sysmex, Tecan, Thermo Fisher, Tosoh.


Infectious Diseases Analyzed in the Report


AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter,

Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium,

Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea,

Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme,

Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps,

Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia and others.


Technology Assessment


- Assessment of molecular diagnostic, monoclonal antibody,

immunoassay, and other technologies and their potential

applications for the microbiology market.


- Global listings of companies developing or marketing microbiology

products by individual test.


Competitive Strategies


- Strategic assessments of major suppliers

and start-up firms developing innovative

technologies and products, including their sales,

product portfolios, marketing tactics, collaborative

arrangements, and new products in R&D.


- The companies analyzed in the report include:


- Abbott

- Affymetrix

- Agilent Technologies

- Applied Gene Technologies

- Arca/Nuvelo

- Beckman Coulter/Danaher

- Becton Dickinson

- Biokit

- bioMerieux

- Bio-Rad

- Biotest

- Caliper

- Cepheid

- Decode

- Diadexus

- Diamedix

- DiaSorin

- Eiken Chemical

- Enzo Biochem

- Exact Sciences

- Fujirebio/Innogenetics

- Hologic/Gen-Probe

- Illumina

- ID Biomedical/GSK

- Kreatech

- Li-Cor Biosciences

- Lonza

- Monogram Biosciences

- Myriad Genetics

- Nanogen/Elitech

- Novartis Diagnostics/Grifols

- Orchid CellMark

- Ortho-Clinical Diagnostics

- Proteome Sciences

- Qiagen

- Roche

- Scienion

- Sequenom

- SeraCare

- Siemens

- Sierra Molecular

- Shimadzu

- Takara Bio

- Tecan

- Thermo Fisher/Life Technology

- Wallac/PE

- Wako


Contains 415 pages and72 tables

Please Select Format

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

Global Blood Plasma Derivatives Market (Type, Application and Geography) - Size, Share, Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2014 - 2020

Blood plasma is the liquid component of blood constituting the extracellular matrix. Blood plasma plays a crucial role in maintaining the electrolyte and osmotic balance whilst preventing infection and blood ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

World Life Science and Chemical Instrumentation Market - Opportunities and Forecasts, 2015 - 2020

Life science and chemical instrumentation is used in research & development activities in industrial laboratories, biotechnology industry, pharmaceutical industries, and academic institutes. It is also used in testing the quality ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Veterinary Diagnostics Market (Products, Animals, Application and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Veterinary diagnostics are noninvasive methods used to identify and examine the causes of diseases in animals. Various new technologies from human diagnostics segments are being adapted for the veterinary domain. This trend is expected to continue in the future, thereby contributing to the growth of this market.

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Tissue Engineering and Regeneration Market (Technology, Applications and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2012 - 2020

Tissue engineering is the combination of biology medicine and engineering to create products that would improve or replace biological functions or organs. More than a decade ago, the industry introduced ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Therapies and Diagnostics for Cervical Cancer Market, (Types, Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2012 - 2020

Cancer has been globally affecting 10million people and it is expected to increase by 2.4% by 2020, reaching to 14 million. Cervical Cancer is a form of cancer that forms ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

World Plasma Fractionation Market - Opportunities and Forecasts, 2015 - 2020

Plasma fractionation is a process of separating various components of plasma. It is used in in prevention and treatment of life threatening diseases caused by trauma, immunologic disorders, and infections. ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

2017 © Copyright Big Market Research

View Pricing >>